论文部分内容阅读
目的在脑梗死患者治疗期间采用综合康复治疗联合叶酸、甲钴胺治疗,探究其对患者血同型半胱氨酸水平的影响。方法该次探究需要利用自愿参与原则在该院所收治的脑梗死患者中选取48例作为样本人群,就诊时间段是2015年8月—2016年8月,按照随机数字表法对48例患者实行均分,2组患者分别命名为研究组和参照组,每组24例患者。对于参照组患者来说,在治疗过程中应用叶酸、甲钴胺治疗,对于研究组患者来说,在治疗过程中应用综合康复治疗联合叶酸、甲钴胺治疗,将2组患者实行不同治疗后得到的组间数据进行统计学分析,计算出统计学分析结果的相关性数值。结果研究组患者血Hcy水平、MBT评分显著性更佳,对比参照组患者而言,组间差异有统计学意义(P<0.05)。结论在脑梗死患者治疗期间采用综合康复治疗联合叶酸、甲钴胺治疗可促进患者功能障碍恢复以及减轻对患者血同型半胱氨酸水平的影响,值得临床推荐。
Objective To observe the effect of combined therapy of folic acid and mecobalamin on the level of plasma homocysteine in patients with cerebral infarction during treatment. Methods The study need to use the principle of voluntary participation in the hospital admitted 48 patients with cerebral infarction selected as the sample population, treatment time period is August 2015 - August 2016, in accordance with the random number table method for 48 patients Two groups of patients were named as study group and reference group, with 24 patients in each group. For the reference group of patients, the application of folic acid, mecobalamin treatment in the treatment process, the study group of patients, the application of comprehensive rehabilitation treatment combined with folic acid, mecobalamin treatment, the two groups of patients after different treatment The data obtained between the groups were statistically analyzed and the correlation values of the statistical analysis results were calculated. Results The serum Hcy levels in the study group were significantly better than those in the reference group, with significant differences in the MBT scores (P <0.05). Conclusion The combination of comprehensive rehabilitation and folic acid during the treatment of patients with cerebral infarction, mecobalamin treatment can promote the recovery of patients with dysfunction and reduce the impact on the level of plasma homocysteine in patients, it is worth recommending.